Regen BioPharma, Inc. RGBPP Stock
Regen BioPharma, Inc. Price Chart
Regen BioPharma, Inc. RGBPP Financial and Trading Overview
| Regen BioPharma, Inc. stock price | 3.2 USD |
| Previous Close | 5 USD |
| Open | 5.01 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 5.01 - 5.01 USD |
| 52 Week Range | 0.004 - 11.62 USD |
| Volume | 142 USD |
| Avg. Volume | 168 USD |
| Market Cap | 187.02M USD |
| Beta (5Y Monthly) | 3.371478 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.017 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RGBPP Valuation Measures
| Enterprise Value | 17.43M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 791.7252 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 73.793 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Regen BioPharma, Inc. Stock Price History
| Beta (5Y Monthly) | 3.371478 |
| 52-Week Change | 25993.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.62 USD |
| 52 Week Low | 0.004 USD |
| 50-Day Moving Average | 3.63 USD |
| 200-Day Moving Average | 1.71 USD |
RGBPP Share Statistics
| Avg. Volume (3 month) | 168 USD |
| Avg. Daily Volume (10-Days) | 64 USD |
| Shares Outstanding | 158.73M |
| Float | 3.38M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:1500 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | 28982.69% |
| Operating Margin (ttm) | -296.086% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -84.26% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 236.21K USD |
| Revenue Per Share (ttm) | 0.07 USD |
| Quarterly Revenue Growth (yoy) | 1.19% |
| Gross Profit (ttm) | 235.52K USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | 68.05M USD |
| Diluted EPS (ttm) | -0.017 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 87.7K USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 611.59K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.034 |
| Book Value Per Share (mrq) | -1.458 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -272472 USD |
| Levered Free Cash Flow (ttm) | -69534720 USD |
Profile of Regen BioPharma, Inc.
| Country | United States |
| State | CA |
| City | La Mesa |
| Address | 4700 Spring Street |
| ZIP | 91942 |
| Phone | 619 722 5505 |
| Website | https://regenbiopharmainc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is also involved in the development of its products, and therapies, including HemaXellarate, a cellular composition of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
Q&A For Regen BioPharma, Inc. Stock
What is a current RGBPP stock price?
Regen BioPharma, Inc. RGBPP stock price today per share is 3.2 USD.
How to purchase Regen BioPharma, Inc. stock?
You can buy RGBPP shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Regen BioPharma, Inc.?
The stock symbol or ticker of Regen BioPharma, Inc. is RGBPP.
Which industry does the Regen BioPharma, Inc. company belong to?
The Regen BioPharma, Inc. industry is Biotechnology.
How many shares does Regen BioPharma, Inc. have in circulation?
The max supply of Regen BioPharma, Inc. shares is 37.33M.
What is Regen BioPharma, Inc. Price to Earnings Ratio (PE Ratio)?
Regen BioPharma, Inc. PE Ratio is now.
What was Regen BioPharma, Inc. earnings per share over the trailing 12 months (TTM)?
Regen BioPharma, Inc. EPS is -0.017 USD over the trailing 12 months.
Which sector does the Regen BioPharma, Inc. company belong to?
The Regen BioPharma, Inc. sector is Healthcare.